Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Danaher Corp (DHR)

Danaher Corp (DHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Danaher's Premium Multiple Meets the Masimo Integration Reality Check Tomorrow

Danaher Corporation reports first-quarter 2026 earnings tomorrow morning before the bell, with Wall Street expecting $1.94 per share—a modest 3.2% gain from the year-ago quarter. The central question: can the company's core revenue growth trajectory justify a premium valuation after shares have declined 6.8% over the past year, underperforming both the S&P 500 and healthcare sector peers? With analysts projecting 7.7% full-year EPS growth to $8.40 and the stock trading at nearly 30 times forward earnings, tomorrow's results will test whether operational momentum can support the bullish consensus or if recent weakness signals emerging headwinds.

Danaher Corporation is a Washington, D.C.-based global science and technology company...

Fundamentals

See More
  • Market Capitalization, $K 138,355,152
  • Shares Outstanding, K 707,699
  • Annual Sales, $ 24,568 M
  • Annual Income, $ 3,614 M
  • EBIT $ 4,690 M
  • EBITDA $ 7,137 M
  • 60-Month Beta 0.95
  • Price/Sales 5.61
  • Price/Cash Flow 17.13
  • Price/Book 2.62

Options Overview Details

View History
  • Implied Volatility 31.67% (-4.45%)
  • Historical Volatility 28.42%
  • IV Percentile 67%
  • IV Rank 52.38%
  • IV High 40.44% on 10/01/25
  • IV Low 22.02% on 12/24/25
  • Expected Move (DTE 3) 4.89 (2.51%)
  • Put/Call Vol Ratio 0.28
  • Today's Volume 12,020
  • Volume Avg (30-Day) 4,895
  • Put/Call OI Ratio 0.77
  • Today's Open Interest 73,019
  • Open Int (30-Day) 64,151
  • Expected Range 189.65 to 199.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $1.94
  • Number of Estimates 10
  • High Estimate $1.98
  • Low Estimate $1.93
  • Prior Year $1.88
  • Growth Rate Est. (year over year) +3.19%

Price Performance

See More
Period Period Low Period High Performance
1-Month
181.01 +7.47%
on 03/27/26
200.50 -2.97%
on 04/21/26
+5.19 (+2.74%)
since 03/20/26
3-Month
181.01 +7.47%
on 03/27/26
242.80 -19.88%
on 01/22/26
-47.51 (-19.63%)
since 01/21/26
52-Week
180.03 +8.06%
on 09/25/25
242.80 -19.88%
on 01/22/26
+9.58 (+5.18%)
since 04/21/25

Most Recent Stories

More News
Danaher (NYSE:DHR) Misses Q1 CY2026 Revenue Estimates

Danaher (NYSE:DHR) Misses Q1 CY2026 Revenue Estimates

DHR : 194.54 (-0.49%)
Danaher: Q1 Earnings Snapshot

Danaher: Q1 Earnings Snapshot

DHR : 194.54 (-0.49%)
Danaher Reports First Quarter 2026 Results

WASHINGTON , April 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2026.  All results in this release reflect only continuing operations and...

DHR : 194.54 (-0.49%)
Danaher's Premium Multiple Meets the Masimo Integration Reality Check Tomorrow

Barchart Research What to Expect from DHR Earnings DHR Generated April 20, 2026 Current Price $195.50 EPS Estimate $$1.94 Consensus Rating Strong Buy Average Move 5.22% Danaher's Premium Multiple Meets...

DHR : 194.54 (-0.49%)
Danaher (DHR) Q1 Earnings: What To Expect

Danaher (DHR) Q1 Earnings: What To Expect

DHR : 194.54 (-0.49%)
Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes

Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems through Fewer Unnecessary Admissions and Testing  

DHR : 194.54 (-0.49%)
Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...

DHR : 194.54 (-0.49%)
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off

1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off

INSP : 52.03 (-8.67%)
BLCO : 16.04 (-4.30%)
DHR : 194.54 (-0.49%)
Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Masimo Corporation...

MASI : 178.43 (-0.01%)
DHR : 194.54 (-0.49%)
What to Expect From Danaher Corporation's Q1 2026 Earnings Report

Danaher Corporation is approaching its first-quarter earnings release in a few weeks, and Wall Street is forecasting a low single-digit percentage rise in earnings.

XLV : 145.92 (-1.02%)
$SPX : 7,064.01 (-0.63%)
MASI : 178.43 (-0.01%)
DHR : 194.54 (-0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of...

See More

Key Turning Points

3rd Resistance Point 209.91
2nd Resistance Point 205.21
1st Resistance Point 199.87
Last Price 194.54
1st Support Level 189.83
2nd Support Level 185.13
3rd Support Level 179.79

See More

52-Week High 242.80
Fibonacci 61.8% 218.82
Fibonacci 50% 211.42
Fibonacci 38.2% 204.01
Last Price 194.54
52-Week Low 180.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.